VCM
GSK icon

Voleon Capital Management’s GSK GSK Stock Holding History

Voleon Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,508
Closed -$324K – 882
2025
Q3 		$324K Buy
+7,508
New +$293K 0.01% 702

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Voleon Capital Management's GSK Position: Q4 2025 in Review

Voleon Capital Management sold out of GSK (GSK) in Q4 2025, closing a stake of 7,508 shares — an estimated $324K sold.

Voleon Capital Management first reported a position in GSK in Q3 2025 and held it in 1 quarter. The position peaked at $324K in Q3 2025. 998 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Voleon Capital Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Voleon Capital Management sold 7,508 GSK shares in Q4 2025, an estimated $324K.
  • Voleon Capital Management first reported a position in GSK in Q3 2025 and held it in 1 quarter.
  • Voleon Capital Management's GSK position peaked at $324K in Q3 2025.
  • 998 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Voleon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.